These results are consistent with other studies, for example, NVP-BEZ235 was found to be cytotoxic to breast cancer cell lines (Serra et al, 2008), whereas MEK inhibitors were reported to be cytostatic (Kohno and Pouyssegur, 2006). The gene discussed is MAP2K7; the disease is breast cancer.